The Valley Desk

NCT05077709 · Interventional trial

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Overall registry status Completed

Phase 2

Conditions Head and Neck Squamous Cell Carcinoma, Lung Cancer Non Small Cell, Urothelial Carcinoma Bladder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov